Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Asthma × laninamivir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Asthma 1

Interventions

Fluticasone-Salmeterol Drug Combination 3 Fluticasone 2 laninamivir 1 fluticasone-formoterol 1 NVP-QAV680 1 Formoterol Fumarate 1 Etanercept 1 Drug Delivery Systems 1 CS 8958 1 Budesonide, Formoterol Fumarate Drug Combination 1 Budesonide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02022761 2018-05-30

Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma

Vaxart

Phase 1 Completed

Asthma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡